Compare ETFs: SURI
SURI
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| SURI | 32.37% | 15.57% | - | - | 3.90% |
Top 25 Holdings
| SURI - Simplify Propel Opportunities ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | PAGP | Plains GP Holdings, L.P. | 30.04% |
| 2 | AKRO | Akero Therapeutics, Inc. | 9.94% |
| 3 | MIST | Milestone Pharmaceuticals Inc. | 7.53% |
| 4 | ACHV | Achieve Life Sciences, Inc. | 7.07% |
| 5 | PHAT | Phathom Pharmaceuticals, Inc. | 5.91% |
| 6 | VRDN | Viridian Therapeutics, Inc. | 4.20% |
| 7 | Cash | Cash | 3.94% |
| 8 | ABEO | Abeona Therapeutics Inc. | 3.40% |
| 9 | DCTH | Delcath Systems, Inc. | 3.27% |
| 10 | CLDX | Celldex Therapeutics, Inc. | 3.14% |
| 11 | n/a | WTS - MILESTONE PHARMACEUTICALS INC SERIES A | 2.62% |
| 12 | OCS | Oculis Holding AG | 2.43% |
| 13 | n/a | ACHIEVE LIFE SCIENCES I WTS 30JUN30 | 2.15% |
| 14 | CMPS | COMPASS Pathways plc | 2.06% |
| 15 | NKTR | Nektar Therapeutics | 2.02% |
| 16 | IVA | Inventiva S.A. | 1.76% |
| 17 | n/a | WTS - MILESTONE PHARMACEUTICALS INC SERIES B | 1.76% |
| 18 | APLT | Applied Therapeutics, Inc. | 1.29% |
| 19 | SABS | SAB Biotherapeutics, Inc. | 0.99% |
| 20 | TELSAT.5.625 12.06.26 144A | TELSAT 5.625 12/06/26 144A Corp | 0.91% |
| 21 | n/a | WTS - QUOIN PHARMACEUTICALS LTD - Pre-funded | 0.82% |
| 22 | ATHA | Athira Pharma, Inc. | 0.72% |
| 23 | n/a | WTS - QUOIN PHARMACEUTICALS LTD - Series H | 0.43% |
| 24 | ZVRA | Zevra Therapeutics, Inc. | 0.41% |
| 25 | n/a | WTS - QUOIN PHARMACEUTICALS LTD - Series I | 0.37% |
| View SURI holdings | |||